Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Pok Tin Tang , Duc H Do , Anthony C Li , et al Added: 3 years ago
Ventricular arrhythmias remain a major contributor to cardiac morbidity and mortality worldwide, despite ongoing research and implementation of novel therapeutic interventions. Modern management of patients with ventricular arrhythmias requires a multidisciplinary team approach, especially in complex presentations with a background of multiple medical comorbidities.1,2 Such teams may include… View more
Author(s): Saagar Mahida , Benjamin Berte , Seigo Yamashita , et al Added: 3 years ago
Since the first catheter ablation for cardiac arrhythmia more than three decades ago, ablation technology has continually evolved at a rapid pace. Much of the early progress in the field was made in ablation of supraventricular tachycardias. Following a seminal study from Haïssaguerre et al.1 in 1998, which demonstrated that pulmonary vein triggers are important sources of atrial fibrillation (AF… View more
Author(s): Jorge E Romero , Ricardo Avendano , Michael Grushko , et al Added: 3 years ago
Oesophageal injury prevention has become a major concern in the field of electrophysiology since the first case of atrio–oesophageal fistula was reported as a complication of endocardial surgical radiofrequency ablation (RFA),1 with Scanavacca et al. and Pappone et al. subsequently reporting this complication in patients who underwent percutaneous pulmonary vein isolation (PVI) for AF.2,3 It is… View more
Author(s): Karl-Heinz Kuck , Andreas Metzner Added: 3 years ago
Catheter-based ablation of atrial fibrillation (AF) is an established treatment option for symptomatic patients who are refractory to drug-based treatment, as implemented in the latest guidelines for the management of AF.1 The accepted and recommended cornerstone of all ablation strategies for AF is electrical isolation of the pulmonary veins (PV).2 However, in addition to PV isolation (PVI),… View more
Author(s): Tim Betts Added: 2 years ago
Global Substrate Mapping and Targeted Ablation with Novel Gold-Tip Catheter in De Novo Persistent AF View more
Research Area(s) / Expertise:
Dr Boris Schmidt is a Cardiologist specialising in Electrophysiology at Cardiologisches Centrum Bethanien in Frankfurt, Germany. Dr Boris Schmidt's scientific activities are focused on catheter ablation of atrial fibrillation and the development of novel single-shot technologies as well as interventional stroke prophylaxis. View more
Author(s): William Eysenck , Magdi Saba Added: 3 years ago
Sir James Mackenzie, famous for describing the first mechanistic insights into AF in 1902 using his polygraph, also reported that AF was present in 80–90% of patients who had congestive heart failure (HF) in 1920.1 Today, the conditions are the two ‘epidemics’ of cardiovascular disease.2 They are dominating cardiovascular care and, with increasing longevity, they will become more prevalent and… View more
Author(s): Tauseef Akhtar , Ronald Berger , Joseph E Marine , et al Added: 3 years ago
AF is a common and clinically impactful arrhythmia. Given both the association of AF with aging and the increasing number of elderly people in the general population, it follows that many AF patients are of advanced age. The management of AF in the geriatric population is associated with several challenges, including multiple comorbidities, increased toxicity of antiarrhythmic drugs (AAD), an… View more
Author(s): Demosthenes G Katritsis , Hein J Wellens , Mark E Josephson Added: 3 years ago
In 1941, Mahaim and Winston described the histology of anomalous connections that arise from the AV node and insert into the right ventricle.1 This was the first description of nodoventricular or so-called Mahaim accessory pathways. Accessory pathways with decremental conduction properties that connected the atrium to the right bundle branch (RBB) were subsequently mapped mainly at the lateral… View more